Azimilide Reduces Emergency Department Visits and Hospitalizations in Patients With an Implantable Cardioverter-Defibrillator in a Placebo-Controlled Clinical Trial

Journal of the American College of Cardiology

Volumn 52, Issue 13, 2008, Pages 1076-1083

  Dorian, Paul ^a   Al Khalidi, Hussein R ^b   Hohnloser, Stefan H ^c   Brum, Jose M ^b   Dunnmon, Preston M ^b   Pratt, Craig M ^d   Holroyde, Michael J ^b   Kowey, Peter ^e  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^c GOETHE UNIVERSITY   (Germany)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

antiarrhythmic therapy; azimilide dihydrochloride; hospitalization; implantable cardioverter defibrillator; recurrent events; ventricular tachycardia storms

Indexed keywords

ACETYLSALICYLIC ACID; AZIMILIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DISEASE CLASSIFICATION; EMERGENCY WARD; HEART ARRHYTHMIA; HEART PACING; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHOCK; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

AGED; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EMERGENCY SERVICE, HOSPITAL; HOSPITALIZATION; HUMANS; IMIDAZOLIDINES; MIDDLE AGED; PIPERAZINES;

EID: 51449084704     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.05.055     Document Type: Article

References (26)

1. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med 335 (1996) 1933-1940
2. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
3. Connolly S.J., Hallstrom A.P., Cappato R., et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 21 (2000) 2071-2078
4. DiMarco J.P. Implantable cardioverter-defibrillators. N Engl J Med 349 (2003) 1836-1847
5. Hohnloser S.H., Al-Khalidi H.R., Pratt C.M., et al. Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial. Eur Heart J 27 (2006) 3027-3032
6. Connolly S.J., Dorian P., Roberts R.S., et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. JAMA 295 (2006) 165-171
7. Dorian P., Borggrefe M., Al-Khalidi H.R., et al. Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation 110 (2004) 3646-3654
8. Lin D.Y., Wei L.J., Yang I., and Ying Z. Semiparametric regression for the mean and rate functions of recurrent events. J R Stat Soc Ser B 62 (2000) 711-730
9. Andersen P.K., and Gill R.D. Cox's regression model for counting processes: a large sample study. Ann Stat 10 (1982) 1100-1120
10. Cook R.J., Lawless J.F., and Nadeau C. Robust tests for treatment comparisons based on recurrent event responses. Biometrics 52 (1996) 557-571
11. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., and Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341 (1999) 1882-1890
12. Exner D.V., Pinski S.L., Wyse D.G., et al. Antiarrhythmics Versus Implantable Defibrillators. Electrical storm presages nonsudden death: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Circulation 103 (2001) 2066-2071
13. Moss A.J., Zareba W., Hall W.J., et al., Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
14. Bardy G.H., Lee K.L., Mark D.B., et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
15. Irvine J., Dorian P., Baker B., et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 144 (2002) 282-289
16. Groh W.J., Bhakta D., Lowe M.R., and Bennett S.J. Come see the softer side of clinical outcomes: quality of life measures in implanted defibrillator trials. J Cardiovasc Electrophysiol 15 (2004) 292-294
17. Godemann F., Butter C., Lampe F., Linden M., Werner S., and Behrens S. Determinants of the quality of life (QOL) in patients with an implantable cardioverter/defibrillator (ICD). Quality Life Res 13 (2004) 411-416
18. Sola C.L., and Bostwick J.M. Implantable cardioverter-defibrillators, induced anxiety, and quality of life. Mayo Clin Proc 80 (2005) 232-237
19. Credner S.C., Klingenheben T., Mauss O., Sticherling C., and Hohnloser S.H. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 32 (1998) 1909-1915
20. Gradaus R., Block M., Brachmann J., et al. Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results from the German ICD Registry EURID. Pacing Clin Electrophysiol 26 (2003) 1511-1518
21. Sesselberg H.W., Moss A.J., McNitt S., Zareba W., Daubert J.P., and Andrews M.L. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm 4 (2007) 1395-1402
22. Verma A., Kilicaslan F., Marrouche N.F., et al. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol 15 (2004) 1265-1270
23. Villacastin J., Almendral J., Arenal A., et al. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators. Circulation 93 (1996) 753-762
24. Pacifico A., Hohnloser S.H., Williams J.H., et al. Prevention of implantable defibrillator shocks by treatment with sotalol. N Engl J Med 340 (1999) 1855-1862
25. Wilkoff B.L., Cook J.R., Epstein A.E., et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator-the Dual Chamber and VVI Implantable Defibrillator (DAVID) trial. JAMA 288 (2002) 3115-3123
26. Nazarian S., Maisel W.H., Miles J.S., Tsang S., Stevenson L.W., and Stevenson W.G. Impact of implantable cardioverter defibrillators on survival and recurrent hospitalization in advanced heart failure. Am Heart J 150 (2005) 955-960